Therapeutic effect of liraglutide on type 2 diabetic patients with nonalcoholic fatty liver disease

Minerva Surg. 2023 Aug;78(4):448-450. doi: 10.23736/S2724-5691.21.09335-7. Epub 2022 Jan 28.

Authors

Limao Xu¹, Chengfeng Wu¹, Chengmin Liu¹, Zhiyao Ye¹, Juan Huang²

Affiliations

¹ Department of Gastroenterology, Pidu District People's Hospital, Chengdu, China.
² Department of Gastroenterology, Pidu District People's Hospital, Chengdu, China - 269463314@qq.com.

PMID: 35088989
DOI: 10.23736/S2724-5691.21.09335-7

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Liraglutide / therapeutic use
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / drug therapy

Substances

Liraglutide
Hypoglycemic Agents